Neurocrine biosciences honored at cares foundation 22nd anniversary gala

San diego , june 6, 2022 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) was honored by the cares foundation for its ongoing research and development of novel therapies for patients with classic congenital adrenal hyperplasia (cah). the cares foundation, inc. is the only u.s.-based nonprofit organization solely dedicated to improving the lives of the cah patient community and seeks to advance quality health care.
NBIX Ratings Summary
NBIX Quant Ranking